UNSPSC 51422312: Methylprednisolone

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H30O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X4W7ZR7023, chemically known as 1,4-butanedioic acid (succinic acid) but generally known as methylprednisolone, which bears US NIH Compound Identifier 1110. European Medicines Agency schedules Methylprednisolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08872MIG.

UNSPSC 51422312 Methylprednisolone is a Commodity code that encompasses pharmaceutical products typically acquired by state and local health agencies, emergency services, and public health departments. The recent solicitation record under this code, however, reflects a significant mismatch: Seminole County, Florida posted an IFB for Naloxone and Safe Drug Deactivation Systems, not methylprednisolone. The county's procurement focuses on overdose-reversal medication and drug disposal equipment, both operationally distinct from corticosteroid pharmaceuticals. State and local issuers using this code tier typically include county health departments, public safety agencies, emergency medical services, and municipal procurement offices acquiring pharmaceuticals for clinical programs, emergency response, or public health initiatives. These jurisdictions generally solicit through competitive bidding (IFB) and request quarterly or regular delivery schedules with fixed pricing and compliance certifications including E-Verify, drug-free workplace, and insurance requirements.

The geographic spread of recent activity under the code is limited to what the source documents. Seminole County, Florida posted the only recent opportunity captured in the dataset, an IFB (IFB60459723LAS) released on June 30, 2026 with a response deadline of July 26, 2023 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly delivery to the Seminole County Community Health Building in Sanford. The opportunity does not specify an explicit dollar value or set-aside designation, though FEMA funding may apply, triggering federal compliance requirements. The misalignment between the code name and the actual solicitation suggests that either the code classification is incorrect for this opportunity or that recent methylprednisolone procurement under this code is not currently visible in state and local notices.